Newton Biocapital
Avenue De Tervueren 273
1150 Woluwe-Saint-Pierre
BE
Newton Biocapital
Foundation date
07/04/2017
Sector
#InvestorSubsector
Newton Biocapital is a Venture Capital Fund incorporated in Belgium, focused on financing biotech and life science projects in the "core of Europe" (B, NL, D, F) and Japan for the prevention and treatment of chronic diseases.
Our approach as lead investor is to support promising start-up projects as well as neglected or undervalued late-stage projects, in order to mitigate the risks and to create investor value. The leadership team consists of specialists with long-standing management and investor experience who coach bio-entrepreneurs through the development stages of their projects.
Upcoming events
All events-
1012 '24
Next-Generation Synthetic Biology
Event by: VIB -
0312 '24
BioFIT 2024
Event by: Eurasanté -
0204 '25
The Franco-Belgian Agrifood Summit
Event by: CCI France - Belgique
Latest news
More news-
New way of twisting fibers improves energy storage in wearable devices
1 hour ago
Read more
-
Bio Base Europe Pilot Plant successfully commissions a 75,000 L fermenter, demonstrating Vivici’s Vivitein™ BLG technology in industrial-scale precision fermentation
1 day ago
Read more
-
argenx Advances Clinical Development of Efgartigimod SC in Idiopathic Inflammatory Myopathies
Wednesday November 20th 2024
Read more
Jobs
More jobs-
-
22/11/24
Flemish Brabant
ERC-funded postdoctoral position on engineering gut bacteria for live biotherapeutic applications
Permanent
VIB -
More info?
Ellen Telleir
Communication Coordinator